Clinical Trial: Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07806617) titled 'Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts' on Sept. 01.

Brief Summary: This study will evaluate whether Gardasil-9, a vaccine normally used to prevent human papillomavirus (HPV) infection, may be effective for treating recurring warts that have not responded to standard treatments. In this study, Gardasil-9 will be injected directly into a wart rather than into a muscle, which is an investigational use of the vaccine. Participants will be randomly assigned to receive injections of either Gardasil-9 or sterile saline (placebo) directly into a wart. Neither the participant nor the clinician administering the inj...